Erik Rollman

1.0k total citations
31 papers, 822 citations indexed

About

Erik Rollman is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Erik Rollman has authored 31 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Virology, 23 papers in Immunology and 8 papers in Infectious Diseases. Recurrent topics in Erik Rollman's work include HIV Research and Treatment (28 papers), Immune Cell Function and Interaction (16 papers) and Immunotherapy and Immune Responses (12 papers). Erik Rollman is often cited by papers focused on HIV Research and Treatment (28 papers), Immune Cell Function and Interaction (16 papers) and Immunotherapy and Immune Responses (12 papers). Erik Rollman collaborates with scholars based in Sweden, Australia and United States. Erik Rollman's co-authors include Jorma Hinkula, Stephen J. Kent, Britta Wahrén, Ivan Stratov, Amy W. Chung, Karl Ljungberg, Andreas Bråve, Andreas Boberg, S. Johansson and Robert De Rose and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and PLoS Pathogens.

In The Last Decade

Erik Rollman

31 papers receiving 812 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Rollman Sweden 17 529 522 219 216 203 31 822
Louisa Tao United Kingdom 15 693 1.3× 703 1.3× 344 1.6× 190 0.9× 176 0.9× 21 1.1k
Zimra R. Israel United States 16 539 1.0× 489 0.9× 304 1.4× 206 1.0× 236 1.2× 21 888
Maria Luisa Visciano United States 14 349 0.7× 362 0.7× 149 0.7× 173 0.8× 126 0.6× 25 626
Agneta von Gegerfelt United States 16 844 1.6× 523 1.0× 273 1.2× 176 0.8× 470 2.3× 20 1.1k
Innocent Mboudjeka United States 18 749 1.4× 371 0.7× 252 1.2× 269 1.2× 402 2.0× 22 1.0k
Georgia R. Krivulka United States 11 776 1.5× 644 1.2× 256 1.2× 297 1.4× 283 1.4× 11 1.0k
Te-Hui Chou United States 15 311 0.6× 331 0.6× 244 1.1× 310 1.4× 221 1.1× 18 782
David C. Montefiori United States 9 589 1.1× 385 0.7× 258 1.2× 175 0.8× 222 1.1× 10 739
Jim Tartaglia United States 16 601 1.1× 545 1.0× 286 1.3× 230 1.1× 202 1.0× 19 897
Florence Boudet France 12 227 0.4× 277 0.5× 170 0.8× 156 0.7× 162 0.8× 25 566

Countries citing papers authored by Erik Rollman

Since Specialization
Citations

This map shows the geographic impact of Erik Rollman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Rollman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Rollman more than expected).

Fields of papers citing papers by Erik Rollman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Rollman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Rollman. The network helps show where Erik Rollman may publish in the future.

Co-authorship network of co-authors of Erik Rollman

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Rollman. A scholar is included among the top collaborators of Erik Rollman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Rollman. Erik Rollman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johansson, S., Erik Rollman, Amy W. Chung, et al.. (2011). NK Cell Function and Antibodies Mediating ADCC in HIV-1-Infected Viremic and Controller Patients. Viral Immunology. 24(5). 359–368. 53 indexed citations
2.
Chung, Amy W., Erik Rollman, Stephen J. Kent, & Ivan Stratov. (2009). Rapid Degranulation of NK Cells following Activation by HIV-Specific Antibodies. The Journal of Immunology. 182(2). 1202–1210. 84 indexed citations
3.
Kent, Stephen J., Robert De Rose, Vladislav V. Mokhonov, et al.. (2008). Evaluation of recombinant Kunjin replicon SIV vaccines for protective efficacy in macaques. Virology. 374(2). 528–534. 19 indexed citations
4.
Boberg, Andreas, Andreas Bråve, S. Johansson, et al.. (2008). Murine models for HIV vaccination and challenge. Expert Review of Vaccines. 7(1). 117–130. 13 indexed citations
5.
Bråve, Andreas, David Hallengärd, Maria Malm, et al.. (2008). Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responses. Vaccine. 27(2). 184–186. 5 indexed citations
6.
Rollman, Erik, Rosemarie D. Mason, Jie Lin, Andrëw G. Brööks, & Stephen J. Kent. (2008). Protection afforded by live attenuated SIV is associated with rapid killing kinetics of CTLs. Journal of Medical Primatology. 37(s2). 24–32. 3 indexed citations
7.
Kent, Stephen J., Robert De Rose, & Erik Rollman. (2007). Drug evaluation: DNA/MVA prime-boost HIV vaccine.. PubMed. 8(2). 159–67. 10 indexed citations
8.
Rollman, Erik, Miranda Z. Smith, Andrëw G. Brööks, et al.. (2007). Killing Kinetics of Simian Immunodeficiency Virus-Specific CD8+ T Cells: Implications for HIV Vaccine Strategies. The Journal of Immunology. 179(7). 4571–4579. 22 indexed citations
9.
Bråve, Andreas, Lindvi Gudmundsdotter, Georg Gasteiger, et al.. (2007). Immunization of mice with the nef gene from Human Immunodeficiency Virus type 1: Study of immunological memory and long-term toxicology. Infectious Agents and Cancer. 2(1). 14–14. 12 indexed citations
10.
Bråve, Andreas, Andreas Boberg, Lindvi Gudmundsdotter, et al.. (2007). A New Multi-clade DNA Prime/Recombinant MVA Boost Vaccine Induces Broad and High Levels of HIV-1-specific CD8+ T-cell and Humoral Responses in Mice. Molecular Therapy. 15(9). 1724–1733. 31 indexed citations
11.
Bråve, Andreas, Jorma Hinkula, Aurelio Cafaro, et al.. (2007). Candidate HIV-1 gp140ΔV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge. Vaccine. 25(39-40). 6882–6890. 10 indexed citations
13.
Applequist, Steven E., Erik Rollman, Mark D. Wareing, et al.. (2005). Activation of Innate Immunity, Inflammation, and Potentiation of DNA Vaccination through Mammalian Expression of the TLR5 Agonist Flagellin. The Journal of Immunology. 175(6). 3882–3891. 76 indexed citations
14.
15.
Bråve, Andreas, Karl Ljungberg, Andreas Boberg, et al.. (2005). Multigene/Multisubtype HIV-1 Vaccine Induces Potent Cellular and Humoral Immune Responses by Needle-Free Intradermal Delivery. Molecular Therapy. 12(6). 1197–1205. 60 indexed citations
16.
Boberg, Andreas, Dan Sjöstrand, Erik Rollman, et al.. (2005). Immunological cross-reactivity against a drug mutated HIV-1 protease epitope after DNA multi-CTL epitope construct immunization. Vaccine. 24(21). 4527–4530. 6 indexed citations
17.
Rollman, Erik, B. Collier, Daniel Öberg, et al.. (2004). HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses. Virology. 322(1). 182–189. 19 indexed citations
18.
Isaguliants, Maria, Sergey Belikov, Elizaveta Starodubova, et al.. (2004). Mutations Conferring Drug Resistance Affect Eukaryotic Expression of HIV Type 1 Reverse Transcriptase. AIDS Research and Human Retroviruses. 20(2). 191–201. 15 indexed citations
19.
Rollman, Erik, Torbjörn Ramqvist, Bartek Zuber, et al.. (2003). Genetic immunization is augmented by murine polyomavirus VP1 pseudocapsids. Vaccine. 21(19-20). 2263–2267. 6 indexed citations
20.
Ljungberg, Karl, Erik Rollman, Lars E. Eriksson, Jorma Hinkula, & Britta Wahrén. (2002). Enhanced Immune Responses After DNA Vaccination with Combined Envelope Genes from Different HIV-1 Subtypes. Virology. 302(1). 44–57. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026